A Selection of Papers from the Meeting on Cancer Science and Targeted Therapy Conference

A special issue of Cancers (ISSN 2072-6694).

Deadline for manuscript submissions: closed (31 March 2021) | Viewed by 722

Special Issue Editors

Department of Life Sciences, Brunel University London, London UB8 3PH, UK
Interests: rare cancers; oncogenic transcription transcription factors; neuroblastoma; neurodegeneration
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue of Cancers will consist of selected papers from the Meeting on Cancer Science and Targeted Therapy Conference (https://www.cancertherapyconference.com/) taking place in Melbourne (Australia), on 23–25 March 2020.

We are pleased to announce the Cancer Therapy 2020 scientific meeting on 23–25 March 2020 in Melbourne. Although cancer still poses a formidable challenge to clinicians and researchers, recent advances in omics, single-cell analyses, and computational biology are closing the gap towards reaching the goal of developing therapies tailored to single-patient needs. Furthermore, major discoveries in the field of cancer immunotherapy and its combination with molecularly targeted approaches have led to the optimistic view that more effective treatments for the most challenging solid tumors, such as lung, pancreatic, and brain cancers, will be eventually available. We, therefore, invite national and international eminent researchers to discuss basic research, translational research, and clinical trials.

The meeting aims to bring together pioneers in basic and translational cancer research interested in all aspects of oncology including cancer genomics, biology, endocrinology, signaling, immunology and, also, novel diagnostic methods.

There will be a particular focus on the development of new biomarkers and “out of the box”, innovative therapeutic strategies. This Special Issue will publish the most exciting and timely research papers presented at the conference.

Prof. Dr. Marco Falasca
Prof. Dr. Arturo Sala
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer treatment
  • cancer immunotherapy
  • cancer genomics
  • cell signaling

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop